Investigators from University of Connecticut Report New Data on Hydroxyprogesterone Caproate Therapy [Regional Differences In Utilization of 17α-hydroxyprogesterone Caproate (17-ohp)].
In: Health Insurance Week, 2023-11-03, S. 1256-1256
serialPeriodical
Zugriff:
Hartford, State:Connecticut, United States, North and Central America, 17-alpha-Hydroxyprogesterone Therapy, Acyclic Acids, Caproates, Drugs and Therapies, Gonadal Hormones, Gonadal Steroid Hormones, Health and Medicine, Hydroxyprogesterone Caproate Therapy, Managed Care, Pharmaceuticals, Progesterone, Progesterone Congeners, Hydroxyprogesterones Keywords for this news article include: Hartford, Connecticut, United States, North and Central America, 17-alpha-Hydroxyprogesterone Therapy, Acyclic Acids, Caproates, Drugs and Therapies, Gonadal Hormones, Gonadal Steroid Hormones, Health and Medicine, Hydroxyprogesterone Caproate Therapy, Hydroxyprogesterones, Managed Care, Pharmaceuticals, Progesterone, Progesterone Congeners, University of Connecticut. Keywords: Hartford; State:Connecticut; United States; North and Central America; 17-alpha-Hydroxyprogesterone Therapy; Acyclic Acids; Caproates; Drugs and Therapies; Gonadal Hormones; Gonadal Steroid Hormones; Health and Medicine; Hydroxyprogesterone Caproate Therapy; Hydroxyprogesterones; Managed Care; Pharmaceuticals; Progesterone; Progesterone Congeners EN Hartford State:Connecticut United States North and Central America 17-alpha-Hydroxyprogesterone Therapy Acyclic Acids Caproates Drugs and Therapies Gonadal Hormones Gonadal Steroid Hormones Health and Medicine Hydroxyprogesterone Caproate Therapy Hydroxyprogesterones Managed Care Pharmaceuticals Progesterone Progesterone Congeners 1256 1256 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health Insurance Week -- Current study results on Drugs and Therapies - Hydroxyprogesterone Caproate Therapy have been published. [Extracted from the article]
Copyright of Health Insurance Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Investigators from University of Connecticut Report New Data on Hydroxyprogesterone Caproate Therapy [Regional Differences In Utilization of 17α-hydroxyprogesterone Caproate (17-ohp)].
|
---|---|
Zeitschrift: | Health Insurance Week, 2023-11-03, S. 1256-1256 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1552-5384 (print) |
Schlagwort: |
|
Sonstiges: |
|